BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29459177)

  • 1. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.
    Mohamed HT; El-Husseiny N; El-Ghonaimy EA; Ibrahim SA; Bazzi ZA; Cavallo-Medved D; Boffa MB; El-Shinawi M; Mohamed MM
    Curr Probl Cancer; 2018; 42(2):215-230. PubMed ID: 29459177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
    Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
    Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.
    Mohamed MM; El-Ghonaimy EA; Nouh MA; Schneider RJ; Sloane BF; El-Shinawi M
    Int J Biochem Cell Biol; 2014 Jan; 46():138-47. PubMed ID: 24291763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas.
    El-Nadi M; Hassan H; Saleh ME; Nassar E; Ismail YM; Amer M; Greve B; Götte M; El-Shinawi M; Ibrahim SA
    Matrix Biol Plus; 2020 May; 6-7():100030. PubMed ID: 33543027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells.
    Masuda Y; Yazawa J; Makino Y; Takada K
    Biol Pharm Bull; 2015; 38(10):1529-35. PubMed ID: 26424017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer.
    Chengwei X; Xiaoli M; Yuan Z; Li P; Shengjiang W; Chao Y; Yunshan W
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):698-703. PubMed ID: 23624357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
    Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
    Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression.
    El-Shinawi M; Mohamed HT; Abdel-Fattah HH; Ibrahim SA; El-Halawany MS; Nouh MA; Schneider RJ; Mohamed MM
    Ann Surg Oncol; 2016 Feb; 23(2):494-502. PubMed ID: 26508152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.
    Salem I; Alsalahi M; Chervoneva I; Aburto LD; Addya S; Ott GR; Ruggeri BA; Cristofanilli M; Fernandez SV
    Breast Cancer Res; 2016 Mar; 18(1):37. PubMed ID: 27009091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-alpha agonists repress expression of thrombin-activatable fibrinolysis inhibitor by decreasing transcript stability.
    Masuda Y; Saotome D; Takada K; Sugimoto K; Sasaki T; Ishii H
    Thromb Haemost; 2012 Jul; 108(1):74-85. PubMed ID: 22535242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mRNA encoding TAFI is alternatively spliced in different cell types and produces intracellular forms of the protein lacking TAFIa activity.
    Lin JH; Novakovic D; Rizzo CM; Zagorac B; Garand M; Filipieva A; Koschinsky ML; Boffa MB
    Thromb Haemost; 2013 Jun; 109(6):1033-44. PubMed ID: 23595589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
    Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone.
    Garand M; Lin JH; Zagorac B; Koschinsky ML; Boffa MB
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):393-404. PubMed ID: 23429253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.
    Shao Z; Nishimura T; Leung LL; Morser J
    J Thromb Haemost; 2015 Jun; 13(6):1090-102. PubMed ID: 25851247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis.
    Mook-Kanamori BB; Valls Serón M; Geldhoff M; Havik SR; van der Ende A; Baas F; van der Poll T; Meijers JC; P Morgan B; Brouwer MC; van de Beek D
    J Thromb Haemost; 2015 Nov; 13(11):2076-86. PubMed ID: 26340319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma thrombin-activatable fibrinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients.
    Kamal HM; Ahmed AS; Fawzy MS; Mohamed FA; Elbaz AA
    Acta Cardiol; 2011 Aug; 66(4):483-8. PubMed ID: 21894805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAF1) with blood pressure.
    Koschinsky ML; Boffa MB; Nesheim ME; Zinman B; Hanley AJ; Harris SB; Cao H; Hegele RA
    Clin Genet; 2001 Nov; 60(5):345-9. PubMed ID: 11903334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.
    Bazzi ZA; Lanoue D; El-Youssef M; Romagnuolo R; Tubman J; Cavallo-Medved D; Porter LA; Boffa MB
    BMC Cancer; 2016 May; 16():328. PubMed ID: 27221823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
    Anfossi S; Giordano A; Gao H; Cohen EN; Tin S; Wu Q; Garza RJ; Debeb BG; Alvarez RH; Valero V; Hortobagyi GN; Calin GA; Ueno NT; Woodward WA; Reuben JM
    PLoS One; 2014; 9(1):e83113. PubMed ID: 24416156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition.
    Takada K; Seike T; Sasaki T; Masuda Y; Ito A; Ishii H
    Thromb Haemost; 2013 Jun; 109(6):1060-9. PubMed ID: 23572161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.